Covalent irreversible usp7 inhibitors for cancer immunotherapy

被引：1

作者：

Kumar, Suresh ^{[1
]}

Wu, Jian ^{[1
]}

Wang, Feng ^{[1
]}

Wang, Liqing ^{[2
]}

Chen, Lee ^{[1
]}

Sokirniy, Ivan ^{[1
]}

Wang, Hui ^{[1
]}

Sterner, David ^{[1
]}

Grove, Charles ^{[1
]}

Cunnion, Brigid ^{[1
]}

Weinstock, Joseph ^{[1
]}

Mattern, Michael ^{[1
]}

Hancock, Wayne ^{[1
]}

机构：

[1] Progenra Inc, Malvern, PA USA

[2] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA

来源：

MOLECULAR CANCER THERAPEUTICS | 2018年 / 17卷 / 01期

关键词：

D O I：

10.1158/1535-7163.TARG-17-B202

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

B202

引用

页数：2

共 50 条

[21] Identification and Characterization of USP7 Targets in Cancer Cells
Georges, Anna
Marcon, Edyta
Greenblatt, Jack
Frappier, Lori
SCIENTIFIC REPORTS, 2018, 8
[22] Selective Inhibition of USP7
Menard, Robert
Sulea, Traian
CHEMISTRY & BIOLOGY, 2012, 19 (04): : 437 - 438
[23] An Integrated Computational Approach for the Discovery of Ubiquitin Specific Protease 7 (USP7) Inhibitors as Potential Cancer Therapies
Durdagi, Serdar
BIOPHYSICAL JOURNAL, 2020, 118 (03) : 47A - 47A
[24] USP7 small-molecule inhibitors interfere with ubiquitin binding
Kategaya, Lorna
Di Lello, Paola
Rouge, Lionel
Pastor, Richard
Clark, Kevin R.
Drummond, Jason
Kleinheinz, Tracy
Lin, Eva
Upton, John-Paul
Prakash, Sumit
Heideker, Johanna
McCleland, Mark
Ritorto, Maria Stella
Alessi, Dario R.
Trost, Matthias
Bainbridge, Travis W.
Kwok, Michael C. M.
Ma, Taylur P.
Stiffler, Zachary
Brasher, Bradley
Tang, Yinyan
Jaishankar, Priyadarshini
Hearn, Brian R.
Renslo, Adam R.
Arkin, Michelle R.
Cohen, Frederick
Yu, Kebing
Peale, Frank
Gnad, Florian
Chang, Matthew T.
Klijn, Christiaan
Blackwood, Elizabeth
Martin, Scott E.
Forrest, William F.
Ernst, James A.
Ndubaku, Chudi
Wang, Xiaojing
Beresini, Maureen H.
Tsui, Vickie
Schwerdtfeger, Carsten
Blake, Robert A.
Murray, Jeremy
Maurer, Till
Wertz, Ingrid E.
NATURE, 2017, 550 (7677) : 534 - +
[25] Discovery of Specific Inhibitors of Human USP7/HAUSP Deubiquitinating Enzyme
Reverdy, Celine
Conrath, Susan
Lopez, Roman
Planquette, Cecile
Atmanene, Cedric
Collura, Vincent
Harpon, Jane
Battaglia, Veronique
Vivat, Valerie
Sippl, Wolfgang
Colland, Frederic
CHEMISTRY & BIOLOGY, 2012, 19 (04): : 467 - 477
[26] Discovery and characterization of highly potent and selective allosteric USP7 inhibitors
Gerald Gavory
Colin R O'Dowd
Matthew D Helm
Jakub Flasz
Elias Arkoudis
Anthony Dossang
Caroline Hughes
Eamon Cassidy
Keeva McClelland
Ewa Odrzywol
Natalie Page
Oliver Barker
Hugues Miel
Timothy Harrison
Nature Chemical Biology, 2018, 14 : 118 - 125
[27] Conformational stabilization of ubiquitin yields potent and selective inhibitors of USP7
Zhang Y.
Zhou L.
Rouge L.
Phillips A.H.
Lam C.
Liu P.
Sandoval W.
Helgason E.
Murray J.M.
Wertz I.E.
Corn J.E.
Nature Chemical Biology, 2013, 9 (1) : 51 - 58
[28] Active site-targeted covalent irreversible inhibitors of USP7 impair the functions of Foxp3+T-regulatory cells by promoting ubiquitination of Tip60
Wang, Feng
Wang, Liqing
Wu, Jian
Sokirniy, Ivan
Phuong Nguyen
Bregnard, Thomas
Weinstock, Joseph
Mattern, Michael
Bersonova, Irina
Hancock, Wayne W.
Kumar, Suresh
PLOS ONE, 2017, 12 (12):
[29] Discovery and characterization of novel, highly potent and selective USP7 inhibitors
Gavory, Gerald
O'dowd, Colin
McClelland, Keeva
Odrzywol, Ewa
Brown, Alan
Burton, Stephanie
Barker, Oliver
Burkamp, Frank
Heim, Matt
James, Iain
Flasz, Jakub
Arkoudis, Elias
Harrison, Tim
CANCER RESEARCH, 2015, 75
[30] Identification and characterization of specific inhibitors of USP7/HAUSP deubiquitinating enzyme
Colland, F.
Reverdy, C.
Conrath, S.
Lopez, R.
Planquette, C.
Collura, V.
Guedat, P.
Delansorne, R.
Daviet, L.
EJC SUPPLEMENTS, 2010, 8 (07): : 36 - 36

← 1 2 3 4 5 →